Advertisement
Screener

T2 Biosystems, Inc. Form PRE 14A: Preliminary proxy statement

T2 Biosystems, Inc. Form PRE 14A: Preliminary proxy statement

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2025-01-08: Form PRE 14A; Period of report 2025-03-03; Description PRE 14A; Document d918954dpre14a.htm.
  • 2024-11-08: Form PRE 14A; Period of report 2024-12-30; Description PRE 14A; Document d849286dpre14a.htm.
  • 2024-02-15: Form PRE 14A; Period of report 2024-04-11; Description PRE 14A; Document d793850dpre14a.htm.
  • 2023-07-12: Form PRE 14A; Period of report 2023-07-28; Description PRE 14A; Document d442934dpre14a.htm.
FiledFormPeriod of reportDescriptionDocument
2025-01-08PRE 14A2025-03-03PRE 14Ad918954dpre14a.htm
2024-11-08PRE 14A2024-12-30PRE 14Ad849286dpre14a.htm
2024-02-15PRE 14A2024-04-11PRE 14Ad793850dpre14a.htm
2023-07-12PRE 14A2023-07-28PRE 14Ad442934dpre14a.htm
2022-08-15PRE 14A2022-10-11PRE 14Ad378569dpre14a.htm
2021-05-03PRE 14A2021-06-25PRE 14Ad23237dpre14a.htm
2020-06-15PRE 14A2020-08-06PRELIMINARY PROXY STATEMENTd891385dpre14a.htm